Kymera Therapeutics
Adding Roles, last update 1 day ago
Pharma biotech · Headquarters United States
Everything we hold on Kymera Therapeutics, newest first. Every line links to the filing or report it came from.
- 2026-08-20Adding Roles Growing and expanding
Kymera Therapeutics opened 5 more roles in United States (job board: 23 to 28)
A board that grows week on week is the earliest public evidence of hiring intent an employer produces: it moves before any announcement and before any filing. Treat the direction as the reliable part and the exact count as approximate, since roles are reposted, split across locations and withdrawn without notice.
- 2026-06-08Headcount Not Stated Leadership moves
Kymera Therapeutics, Inc. 8-K filing (Item 5.02): officer or director change
Kymera Therapeutics' COO steps down in Watertown, with no immediate replacement announced.
- 2025-12-31Pay Change Pay and benefits
KYMERA THERAPEUTICS, INC.: $8,545,609 total compensation for the principal executive officer, fiscal year ended 2025-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2024-12-31Pay Change Pay and benefits
KYMERA THERAPEUTICS, INC.: $15,433,147 total compensation for the principal executive officer, fiscal year ended 2024-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2023-12-31Pay Change Pay and benefits
KYMERA THERAPEUTICS, INC.: $9,670,542 total compensation for the principal executive officer, fiscal year ended 2023-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2022-12-31Pay Change Pay and benefits
KYMERA THERAPEUTICS, INC.: $6,926,645 total compensation for the principal executive officer, fiscal year ended 2022-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
Kymera Therapeutics. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 21, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/kymera-therapeutics/ Licensed CC BY 4.0; every record links to the document behind it.The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker